Search PubMed⌕ Search

Biomedical subjects

U Mueller

Publications and source records attributed to U Mueller.

35 records · Page 2Linked to original sources

Perturbations in the spi1p GTPase cycle of Schizosaccharomyces pombe through its GTPase-activating protein and guanine nucleotide exchange factor components result in similar phenotypic consequences.

spi1p of Schizosaccharomyces pombe is a structural homolog of the mammalian GTPase Ran. The distribution between the GTP- and GDP-bound forms of the protein is regulated by evolutionarily conserved gene products, rna1p and pim1p, functioning as GTPase-activating protein (GAP) and guanine nucleotide exchange factor (GEF), respectively. Antibodies to spi1p, pim1p, and rna1p were generated and used to demonstrate that pim1p is exclusively nuclear, while rna1p is cytoplasmic. A loss of pim1p GEF activity or an increase in the rna1p GAP activity correlates with a change in the localization of the GTPase from predominantly nuclear to uniformly distributed, suggesting that the two forms are topologically segregated and that the nucleotide-bound state of spi1p may dictate its intracellular localization. We demonstrate that the phenotype of cells overproducing the GAP resembles the previously reported phenotype of mutants with alterations in the GEF: the cells are arrested in the cell cycle as septated, binucleated cells with highly condensed chromatin, fragmented nuclear envelopes, and abnormally wide septa. Consistent with the expectation that either an increased dosage of the GAP or a mutation in the GEF would lead to an increase of the spi1p-GDP/spi1p-GTP ratio relative to that of wild-type cells, overexpression of the GAP together with a mutation in the GEF is synthetically lethal. The similar phenotypic consequences of altering the functioning of the nuclear GEF or the cytoplasmic GAP suggest that there is a single pool of the spi1p GTPase that shuttles between the nucleus and the cytoplasm. Phenotypically, rna1 null mutants, in which spi1p-GTP would be expected to accumulate, resemble pim1(ts) and rna1p-overproducing cells, in which spi1p-GDP would be expected to accumulate. Taken together, these results support the hypothesis that the balance between the GDP- and GTP-bound forms of spi1p mediates the host of nuclear processes that are adversely affected when the functioning of different components of this system is perturbed in various organisms.

Animals↗

Diuretic-related hypokalaemia: the role of diuretics, potassium supplements, glucocorticoids and beta 2-adrenoceptor agonists. Results from the comprehensive hospital drug monitoring programme, berne (CHDM).

All 5,047 consecutive inpatients admitted to the Internal Medicine Division of a teaching hospital (Zieglerspital, Berne) between 1982 and 1985 were registered in accordance with the CHDM (Comprehensive Hospital Drug Monitoring) questionnaire of adverse drug reactions (ADRs). Of them, 2,439 were treated with at least one potassium losing diuretic. The hospital records of the patients were reviewed with particular regard to serum potassium levels, and on the basis of this evaluation, the patients were assigned to four different diuretic treatment groups, and the incidence of hypokalaemia related to diuretic treatment was estimated. The overall rate of occurrence of hypokalaemia was 21.1% at a serum potassium level < 3.5 mmol.l-1, and 3.8% < 3.0 mmol.l-1. Hypokalaemia of less than 3.5 mml.l-1 developed 24.9% (217/870) of patients treated with potassium losing diuretics alone; in 19.7% (101/513) treated with potassium losing diuretics in conjunction with potassium substitution, in 15.1% (66/438) treated with a combination of diuretics (potassium losing with potassium sparing), and in 20.0% (12/60) treated with combined diuretics and potassium substitution. Only the differences between the first and the two subsequent groups were statistically significant. The overall incidence of hypokalaemia below 3.0 + mmol.l-1 was significantly lower in the patients on combined diuretics without potassium substitution than in the patients on potassium losing diuretics with potassium substitution. Oral or parenteral administration of glucocorticoids (prednisone 5 to 2,000 mg/d) was a significant risk factor for hypokalaemic events. beta 2-Adrenoceptor agonists had not effect. The patient's age, sex, renal function and numbers of drugs received were evaluated in a multivariate analysis, in order to take into account their influence on the risk of developing hypokalaemia. The number of drugs above 12 (and, less importantly, female sex) was the main risk factor for this ADR. The comparison between hypokalaemia and hyperkalaemia in this group of inpatients showed the significance of reduced renal function in the occurrence of hyperkalaemia.

Adolescent↗

Prospective study of 713 below-knee amputations for ischaemia and the effect of a prostacyclin analogue on healing. Hawaii Study Group.

In 51 hospitals in six European countries 713 patients requiring below-knee amputation for ischaemic disease were studied prospectively. The patients were allocated randomly to receive standard postoperative treatment or standard treatment plus intravenous infusion of the prostacyclin analogue iloprost for 6 h per day over 14-21 days. Healing of the amputation stump and the need for reamputation at a higher level were similar in the two groups. Overall at 3 months 59 per cent of stumps had healed, 19 per cent of patients had required reamputation at a higher level, 11 per cent had died and the remaining 11 per cent remained with unhealed stumps. Preoperative characteristics were analysed as possible risk factors or markers for primary healing, reamputation and death. Previous arterial reopening procedures (surgical or radiological) almost doubled the chances of primary stump healing (P < 0.05). The surgeon's assessment of the likelihood of healing was wrong in 21 per cent of cases in which the operating surgeon thought that healing would probably occur and in 52 per cent of those in which it was thought healing was improbable.

Adult↗

Functional expression of a human TCR beta gene in transgenic mice.

A functionally rearranged TCR beta (Tcrb) gene was isolated from a cloned human T helper cell recognizing the CS.T3 epitope of Plasmodium falciparum with HLA-DR2. Transgenic mice were generated by co-injection of the human gene together with the mouse Tcrb enhancer. Analysis of transgenic mice shows that the functional Tcrb gene of xenogenic, i.e. human, origin exerts allelic exclusion of endogenous Tcrb genes. Cytofluorometric analysis revealed expression of the human TCR beta chain on virtually all thymocytes and peripheral T cells together with endogenous TCR beta chains and CD3 components. No surface expression of mouse TCR beta chain or rearrangement of endogenous Tcr genes was detectable. Expression of the hybrid receptor causes a reduction in the number of thymocytes and a bias for CD4+CD8- T cells in the thymus as compared with non-transgenic littermates. Peripheral transgenic T cells mount a normal proliferative response against allogeneic targets in mixed lymphocyte reactions. These results show that a hybrid mouse/human TCR is able to pass positive and negative selection in the thymus, and is functional in transgenic mice.

Animals↗

Cross-national reliability, concurrent validity, and stability of a brief method for assessing expressed emotion.

The Five-Minute Speech Sample (FMSS; Magana et al., 1986) is a brief method designed to assess the "expressed emotion" (EE) status of a respondent. The FMSS-EE rating is derived from statements made by a patient's key relative during a 5-minute monologue, with codes similar to those used in the original EE rating system (e.g., criticism and emotional overinvolvement). Rating is done from the audiotape and takes about 15-30 minutes. The article reports on the results of a cross-national study carried out in Germany using the FMSS with a sample of 60 relatives of schizophrenic patients. Results indicated that (1) German investigators could readily learn the system and could achieve a high degree of interrater reliability; (2) the association with the original index of EE, the Camberwell Family Interview, was comparable to that found by Magana et al.; and (3) the method yields very stable data over a 4-5 week retest period.

Adolescent↗

Modified rapid venom desensitization.

The clinical and immunologic response to a modified rapid (r) regimen of venom immunotherapy was evaluated and compared to a traditional (t) therapeutic regimen. Nineteen patients in the r group received a starting dose of 0.01 microgram and reached a maintenance dose of 50 micrograms in 7 weeks. Twelve patients in the t group received an average of twenty-one injections on a weekly basis, reaching the same maintenance dose. The age and sex distribution and pre-treatment venom-specific IgE titres (RAST) of both groups were comparable. There were thirteen local reactions to venom therapy in both groups and no systemic reactions. Following therapy, most patients developed a rising titre of serum venom-specific IgG (V-IgG). Serum venom-specific IgE (V-IgE) changes were similar in the two groups; over half of the patients had a falling titre when on maintenance dose. Twelve patients were re-stung after reaching maintenance dose. Only one developed a mild systemic reaction, an individual who failed to show a V-IgG response with rapid therapy. Five of nine patients did not have an anamnestic V-IgE response. This rapid method of venom immunotherapy appears to be safe, clinically effective, and comparable to traditional dosing without additional adverse reaction.

Adolescent↗

Comparison of the allergenicity and antigenicity of yellow jacket and hornet venoms.

The immunologic properties of yellow jacket and hornet venoms were compared by measuring their reaction with rabbit antisera and human IgE and IgG antibodies. Anti-hornet venom rabbit serum showed precipitin bands unique to hornet venom and several bands crossreacting with yellow jacket venom. Anti-yellow jacket venom rabbit serum reacted with yellow jacket venom but failed to react with the hornet venoms. Most sera from patients who had had allergic reactions after vespid stings reacted with yellow jacket and hornet venoms in RAST analysis. A few sera reacted with only one of the venoms. RAST inhibition studies confirmed the crossreactivity of these IgE antibodies. The IgG antibody response of 14 patients was measured after yellow jacket venom immunotherapy. All had rising titers of yellow jacket venom-specific IgG. There was also an increase in the IgG antibody response measured with hornet venom in the majority of patients. The rise was significant with yellow hornet venom (p less than 0.02) but failed to reach significance with bald-faced hornet venom (p greater than 0.05). In IgG radioimmunoassay inhibition studies using yellow jacket venom-coupled discs, yellow jacket venom was considerably more potent than hornet venom. These studies indicate major crossreactivity between yellow jacket and hornet venoms. In this group of patients, yellow jacket venom appeared to be the primary allergen.

Allergens↗

Studies of chemically modified honeybee venom. I. Biochemical, toxicologic and immunologic characterization.

Allergens of honeybee venom (BV) were modified by formaldehyde treatment (F), acetoacetylation (A) or coupling to polyethylene glycol (P). The biochemical, toxicologic and immunologic properties of these modified BV preparations were analyzed. F showed strongly reduced cytotoxicity, enzymatic activity and reactivity with human BV-specific IgE antibodies but retained the reactivity to BV-specific human and rabbit IgG. In A, enzymatic activity, cytotoxicity and the reactivity with human IgE and rabbit IgG antibodies were only moderately reduced. P lacked enzymatic activity and cytotoxicity and showed only minimal reactivity with IgE and IgG antibodies to BV.

Acetoacetates↗

Studies of chemically modified honeybee venom. II. Immunogenicity and suppression of reaginic antibody formation.

Honeybee venom allergens modified by formaldehyde treatment (F), acetoacetylation (A), and coupling to polyethylene glycol (P) were studied with regard to their immunogenicity and their IgE-suppressive potential in rabbits and mice. F indiced a strong IgG response in rabbits and especially mice, but only a moderate IgE response in the mouse. Its IgE-suppressive potential in mice was comparable to that of unmodified bee venom. A induced only a weak IgG and IgE response. Its IgE-suppressive potential was greater than that of unmodified bee venom. P was nonimmunogenic and had only a marginal IgE-suppressive effect. F and A seem promising for the treatment of bee sting-allergic individuals.

Acetoacetates↗

Local intranasal immunotherapy for ragweed allergic rhinitis. I. Clinical response.

Local nasal immunotherapy (LNIT) of ragweed allergic rhinitis was studied in a double-blind controlled trial. Sixty-seven subjects were divided into three groups. Twenty-one received unmodified ragweed extract (RW), 24 received a glutaraldehyde polymer of ragweed extract (PRW), and 22 received placebo. Mean symptom/medication scores during the season were 2.12, 2.76, and 3.93 for the RW, PRW, and placebo groups, respectively. Both RW- and the PRW-treated group scores were significantly lower than those of the placebo group (p less than 0.01, and p less than 0.025, respectively). The results of the patients' self-evaluations indicated that therapy was effective in 71%, 59%, and 41% for the RW-, PRW-, and placebo-treated groups, respectively. Adverse reactions to treatment were limited to the upper respiratory tract and were noted by all patients. They were significantly more severe in the RW-treated patients than those in the PRW- or placebo-treated groups. We conclude that LNIT is an effective therapy for ragweed allergic rhinitis. The use of a PRW decreased adverse reactions significantly while slightly decreasing the therapeutic benefit.

Administration, Intranasal↗

Local intranasal immunotherapy for ragweed allergic rhinitis. II. Immunologic response.

Local nasal immunotherapy (LNIT) was administered in a double-blind study to 67 subjects. Twenty-three received an unmodified ragweed extract (RW), 24 received a glutaraldehyde polymer of ragweed extract (PRW), and 21 received placebo. Serum ragweed-specific IgE (S-IgE), ragweed-specific nasal secretory (NS-) IgE, secretory IgA (SIgA) and IgG, and NS-albumin were measured. RW therapy caused a significant increase in ragweed-specific S-IgE (p less than 0.005) and NS-SIgA (p less than 0.05). PRW therapy caused a significant rise in ragweed-specific NS-SIgA (p less than 0.001). NS-IgE (p less than 0.05), and NS-IgG (p less than 0.01). Ragweed-specific S-IgG was not affected by any of the treatments. There was no consistent correlation between NS-antibody levels and symptom/medication scores.

Administration, Intranasal↗

Comparison of vespid venoms collected by electrostimulation and by venom sac extraction.

Venoms of three vespid species, yellow jacket, bald-faced hornet, and yellow hornet, obtained by either electrostimulation of venom sac extraction were compared with regard to their enzymatic activity, antigenicity, and allergenicity. Phospholipase a, phospholipase B, and hyaluronidase enzymatic activities were present in all six preparations. The activity of venom sac extracts lay in the range found in different batches of venoms obtained by electrostimulation for each species. Analysis of sera from vespid-sensitive patients in the radioallergosorbent test (RAST) with discs coupled with either venom sac extracts or venoms obtained by electrostimulation showed a good correlation of the results within all three species (r = 0.95). In RAST inhibition the potency of venom sac extracts and venom obtained by electrostimulation was similar for each species. Analysis of rabbit antisera to the six preparations revealed similar patterns in immunoelectrophoresis and identity reactions between the major antigens within each species. Tissue protein contamination was detected in all venom sac extracts but not in venoms obtained by electrostimulation.

Animals↗

Behaviour of bacteriorhodopsin incorporated into lipid vesicles after solubilization with different detergents.

Incorporation of bacteriorhodopsin (BR), derived from the purple membrane by solubilization with detergents, into phosphatidylcholine-(PC-) vesicles resulted in a disperse distribution of the protein particles in the lipid bilayer as revealed by freeze-fracture electron microscopy. Rotational diffusion measurements showed a high rotational mobility when the system is kept above the lipid phase transition temperature (Tc). Below the Tc the particles are immobilized as observed by flash photolysis while in electron micrographs, segregation of the protein from the lipids and particle aggregation can be seen. In some cases a hexagonal lattice is observed. Solubilization of the purple membrane with LDAO (lauryl-dimethyl-amine oxide) followed by centrifugation through a sucrose density gradient resulted in BR depleted by 80% of bacterial lipids. Incorporation of this lipid-depleted BR into PC-vesicles did not reveal any significant differences in its mobility of its aggregation behaviour. Incorporation of cholesterol into the vesicle system resulted in a marked immobilization of BR. Freeze-fracture electron micrographs show typical segregation phenomena above the Tc of the pure lipid. In the sample with 30 mole% cholesterol, aggregation of the protein appears to be accompanied by lattice formation.

Bacteriorhodopsins↗

[Determinatives of the understanding and judging of the speech-impaired's language on the part of speech-functioning people.-An empirical study (author's transl)].

The purpose of the study was to find out the individual and social factors influencing the understanding and judging of the speech-defective's language by speech-functioning persons. In contrast to prevailing opinions, it was proven that the evaluation is not controlled by "adopted" prejudices, but by the real understanding of linguistic and paralinguistic components of language. Within this context, the level of understanding and the significance of these two components in view of the evaluation depends on the sociolinguistic milieu to which the speech-functioning individual belongs.

Adult↗

Association analysis of genes involved in cholesterol metabolism located within the linkage region on chromosome 10 and Alzheimer's disease.

Epidemiological studies identified a higher risk of developing Alzheimer's disease (AD) among subjects with elevated cholesterol levels. This association may be caused by a modulation of the amyloid precursor protein (APP) processing in response to the cellular cholesterol content. High cholesterol levels may favor the amyloidogenic pathway by inhibition of the alpha-secretase probably leading to elevated beta-Amyloid (Abeta) production. The identification of a linkage peak on chromosome 10q using high Abeta as quantitative trait led us to examine polymorphisms of genes located on chromosome 10 involved in cholesterol metabolism, like Lipase A (LIPA), Cholesterol 25 hydroxylase (CH25H), and FLJ22476, a high density lipoprotein binding related protein. Using 286 patients with AD and 162 controls we analyzed several single nucleotide polymorphisms (SNPs) within LIPA, CH25H, and FLJ22476. None of the polymorphisms showed significant association with AD which contradicts recent findings on CH25H. From our results we conclude that the investigated genetic variations do not contribute to the genetic risk of AD.

Aged↗